Shares in Shanghai Fosun Pharmaceutical tumbled as much as 12 per cent on their Hong Kong market debut on Tuesday, suggesting a rough ride ahead for Zhengzhou Coal Mining Machinery, the People’s Insurance Company of China and other Chinese groups still hoping to raise money this year.
复星医药(Fosun Pharmaceutical)周二在香港股市交易首日,盘中股价一度下跌12%。这预示着,包括郑州煤矿机械集团(Zhengzhou Coal Mining Machinery)、中国人保(PICC)等数家仍希望于年内在香港融资的中资集团将面临不平坦的上市之路。
Shanghai-listed Fosun raised $512m when it priced its Hong Kong initial public offering last week, at the low end of its expected range and with only just enough institutional and regional interest to fill its order books.
先前已在上海上市的复星医药上周以招股价下限为其香港IPO定价,筹得资金5.12亿美元,机构和本地散户投资者没有超额认购。
Nevertheless, others are expected to press ahead with planned Hong Kong listings. Zhengzhou Coal Mining Machinery is due to proceed with the roadshow next week for its hoped-for $500m equity raising, although one banker with knowledge of that deal said “don’t hold your breath.
然而,预计其他公司将继续推进香港上市计划。郑州煤矿机械集团将于下周举行路演。这家公司希望筹资5亿美元,不过一位知情银行家表示,“对此不要抱太大希望。
【复星医药香港交易首日表现堪忧】相关文章:
★ 清明节双语介绍
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15